Aurelie Garant, M.D.

Director of Brachytherapy Program

Harold C. Simmons Comprehensive Cancer Center

Radiation Oncology
Brachytherapy
Genitourinary Cancer

New Patient Appointment Accepting Virtual Visits or 214-645-8525

Biography

Aurelie Garant, M.D., is an Associate Professor of Radiation Oncology and Director of the Brachytherapy Program at UT Southwestern Medical Center. She is board certified in radiation oncology by the American Board of Radiology.

Dr. Garant earned her medical degree at Université Laval, Canada, followed by a residency at McGill University Health Centre and a fellowship at Mayo Clinic in advanced radiation oncology. In 2015, she received the McGill University Residency Program award, and in 2017, the John D. Earle Fellowship at the Mayo Clinic.

In 2020, Dr. Garant received a Diploma of the Royal College of Physicians and Surgeons of Canada for focused competency in brachytherapy. Dr. Garant can provide brachytherapy expertise on the following conditions:

Skin cancer
Esophageal cancer
Endobronchial lung cancer
Penile cancer
Rectal cancer
Prostate cancer
Superficial urogenital cancers
Coronary artery restenosis

She can also provide intraoperative radiotherapy services for patients with complex pelvic tumors.

Education & Training

Fellowship - Mayo Clinic (2017-2018), Advanced Radiation Oncology
Residency - McGill University Health Centre (2012-2017), Radiation Oncology
Medical School - Université Laval, Canada (2007-2012)

Honors & Awards

ARRO Educator of the Year 2023
Texas Super Doctors, Rising Star 2023
Texas Super Doctors, Rising Star 2022
Texas Super Doctors, Rising Star 2021
Texas Super Doctors, Rising Star 2020
NIH Kidney Cancer SPORE Career Enhancement Program Award 2019
UT Southwestern Leaders Emerging in Academic Departments (LEAD) Course: Class of 2019 2019
Reviewer (by invitation), International Journal of Radiation Oncology Biology Physics 2018
American Brachytherapy Society Prostate LDR/HDR Scholarship 2018
John D. Earle Radiation Oncology Fellowship Fund, Mayo Clinic, Rochester MN 2017-2018
McGill University Residency Program Award – Scholar 2015-2016
CIHR Travel Award Recipient for research presented abroad 2015
McGill University Residency Program Award – Collaborator/Manager 2014-2015
Chief Resident, Radiation Oncology Residency Program, McGill University, Canada 2014-2015

Books & Publications

Books
- Surgical Techniques in Rectal Cancer in Neoadjuvant Radiotherapy
  Vuong T, Garant A (2018), New York City, Springer
- Current Therapy in Colon and Rectal Surgery in Cancer of the Rectum: Neoadjuvant Therapy
  Vuong T, Garant A, Niazi T (2016), Amsterdam, Elsevier Sciences
Publications
- The Importance of Multiparametric Magnetic Resonance Imaging, Positron Emission Tomography/Computed Tomography, and Biopsy for Identifying and Delineating the Extent of Intraprostatic Radiorecurrent Prostate Cancer: A Secondary Analysis of the F-SHARP Clinical Trial
  Venkatesulu BP, Adams W, Joel R, Ross D, Yoo R, Quick C, Baldea KG, Barkan G, Block A, Bova D, Farooq A, Garant A, Gupta G, Shea SM, Showalter TN, Small W, Welsh JS, Harkenrider MM, Solanki AA International Journal of Radiation Oncology Biology Physics 2025
- The role of the radiologist in the prostate cancer multidisciplinary conference
  Costa DN, Nguyen N, Garant A, Meng X, Courtney KD, Shah RB, Pedrosa I Abdominal Radiology 2024 Nov 49 4162-4172
- Optimising local treatment decisions for rectal cancer
  Jethwa KR, Aujla KS, Garant A The Lancet Gastroenterology and Hepatology 2024 Sep 9 779-781
- Performance deterioration of deep learning models after clinical deployment: a case study with auto-segmentation for definitive prostate cancer radiotherapy
  Wang B, Dohopolski M, Bai T, Wu J, Hannan R, Desai N, Garant A, Yang D, Nguyen D, Lin MH, Timmerman R, Wang X, Jiang SB Machine Learning: Science and Technology 2024 Jun 5
- BIOGUIDE-X: A First-in-Human Study of the Performance of Positron Emission Tomography-Guided Radiation Therapy
  Vitzthum LK, Surucu M, Gensheimer MF, Kovalchuk N, Han B, Pham D, Chang D, Shirvani SM, Aksoy D, Maniyedath A, Narayanan M, Da Silva AJ, Mazin S, Feghali KA, Iyengar P, Dan T, Pompos A, Timmerman R, Öz O, Cai B, Garant A International Journal of Radiation Oncology Biology Physics 2024 Apr 118 1172-1180
- F-SHARP: a Phase I/II trial of focal salvage high-dose-rate brachytherapy for Radiorecurrent prostate cancer
  Solanki AA, Yoo RK, Adams W, Davicioni E, Mysz ML, Shea S, Gupta GN, Showalter T, Garant A, Hentz C, Farooq A, Baldea K, Small W, Harkenrider MM BJU international 2024 Feb 133 188-196
- Bony structure enhanced synthetic CT generation using Dixon sequences for pelvis MR-only radiotherapy
  Liang X, Yen A, Bai T, Godley A, Shen C, Wu J, Meng B, Lin MH, Medin P, Yan Y, Owrangi M, Desai N, Hannan R, Garant A, Jiang S, Deng J Medical physics 2023 Dec 50 7368-7382
- The Crying Need for a Better Response Assessment in Rectal Cancer
  Amintas S, Giraud N, Fernandez B, Dupin C, Denost Q, Garant A, Frulio N, Smith D, Rullier A, Rullier E, Vuong T, Dabernat S, Vendrely V Current treatment options in oncology 2023 Nov 24 1507-1523
- Organ sparing treatment for penile cancer using a 3D-printed high-dose-rate brachytherapy applicator
  Lee HH, Chiu TD, Hrycushko B, Xiong Z, Hudak S, Woldu S, Mauck R, Corwin T, Meng X, Margulis V, Desai N, Folkert MR, Garant A Brachytherapy 2023 Sep 22 580-585
- Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer
  Hannan R, McLaughlin MF, Pop LM, Pedrosa I, Kapur P, Garant A, Ahn C, Christie A, Zhu J, Wang T, Robles L, Durakoglugil D, Woldu S, Margulis V, Gahan J, Brugarolas J, Timmerman R, Cadeddu J European urology 2023 Sep 84 275-286
- Preliminary Evaluation of PTV Margins for Online Adaptive Radiation Therapy of the Prostatic Fossa
  Morgan HE, Wang K, Yan Y, Desai N, Hannan R, Chambers E, Cai B, Lin MH, Sher DJ, Wang J, Wang AZ, Jiang S, Timmerman R, Park C“, Garant A Practical Radiation Oncology 2023 Jul 13 e345-e353
- Evaluation of fan-beam kilovoltage computed tomography image quality on a novel biological-guided radiotherapy platform
  Zhuang T, Gibbard G, Duan X, Tan J, Park Y, Lin MH, Sun Z, Oderinde OM, Lu W, Reynolds Jr. RR, Godley A, Pompos A, Dan T, Garant A, Iyengar P, Timmerman R, Jiang S, Cai B Physics and Imaging in Radiation Oncology 2023 Apr 26
- Artificial Intelligence–Empowered Radiation Oncology Residency Education
  Kwon YS, Dohopolski M, Morgan H, Garant A, Sher D, Rahimi A, Sanford NN, Vo D, Albuquerque K, Kumar K, Timmerman R, Jiang SB Practical Radiation Oncology 2023 Jan 13 8-10
- Stereotactic Ablative Radiation for Systemic Therapy-naïve Oligometastatic Kidney Cancer
  Hannan R, Christensen M, Christie A, Garant A, Pedrosa I, Robles L, Mannala S, Wang C, Hammers H, Arafat W, Courtney K, Bowman IA, Sher D, Ahn C, Cole S, Choy H, Timmerman R, Brugarolas J European Urology Oncology 2022 Dec 5 695-703
- Clinical applications of high dose rate endorectal brachytherapy for patients with rectal cancer
  Vuong T, Garant A, Vendrely V, Martin AG, Devic S Cancer/Radiotherapie 2022 Oct 26 879-883
- Image-Guided Brachytherapy for Rectal Cancer: Reviewing the Past Two Decades of Clinical Investigation
  Vuong T, Garant A, Vendrely V, Nout R, Martin AG, Enger SA, Podgorsak E, Moftah B, Devic S Cancers 2022 Oct 14
- Case Report: Adaptive radiotherapy in the radiation salvage of prostate cancer
  Montalvo SK, Meng B, Lin MH, Park C, Desai NB, Hannan R, Garant A Frontiers in Oncology 2022 Aug 12
- MORPHEUS Phase II–III Study: A Pre-Planned Interim Safety Analysis and Preliminary Results
  Garant A, Vasilevsky CA, Boutros M, Khosrow-Khavar F, Kavan P, Diec H, Des Groseilliers S, Faria J, Ferland E, Pelsser V, Martin AG, Devic S, Vuong T Cancers 2022 Aug 14
- SABR for High-Risk Prostate Cancer: A Prospective Multilevel MRI-Based Dose Escalation Trial
  Hannan R, Salamekh S, Desai NB, Garant A, Folkert MR, Costa DN, Mannala S, Ahn C, Mohamad O, Laine AM, Kim DW, Dickinson T, Raj GV, Shah RB, Wang J, Jia X, Choy H, Roehrborn CG, Lotan Y, Timmerman RD International Journal of Radiation Oncology Biology Physics 2022 Jun 113 290-301
- Phase II Trial of Sipuleucel-T and Stereotactic Ablative Body Radiation for Patients with Metastatic Castrate-Resistant Prostate Cancer
  Hannan R, Dohopolski MJ, Pop LM, Mannala S, Watumull L, Womack KB, Gao A, Garant A, Arriaga YE, Bowman I, Chung J, Wang J, Ariizumi K, Ahn C, Timmerman R, Courtney K Biomedicines 2022 Jun 10
- Phase II Trial of Stereotactic Ablative Radiation for Oligoprogressive Metastatic Kidney Cancer
  Hannan R, Christensen M, Hammers H, Christie A, Paulman B, Lin D, Garant A, Arafat W, Courtney K, Bowman I, Cole S, Sher D, Ahn C, Choy H, Timmerman R, Brugarolas J European Urology Oncology 2022 Apr 5 216-224
- Dose-Intensified Stereotactic Ablative Radiation for Localized Prostate Cancer
  Chen L, Gannavarapu BS, Desai NB, Folkert MR, Dohopolski M, Gao A, Ahn C, Cadeddu J, Bagrodia A, Woldu S, Raj GV, Roehrborn C, Lotan Y, Timmerman RD, Garant A, Hannan R Frontiers in Oncology 2022 Feb 12
- Metastasis-directed radiation therapy after radical cystectomy for bladder cancer
  Miranda AF, Howard JM, McLaughlin M, Meng X, Clinton T, Şanli Ö, Garant A, Bagrodia A, Margulis V, Lotan Y, Hannan R, Desai N, Woldu SL Urologic Oncology: Seminars and Original Investigations 2021 Nov 39 790.e1-790.e7
- PSA-Net: Deep learning–based physician style–aware segmentation network for postoperative prostate cancer clinical target volumes
  Balagopal A, Morgan H, Dohopolski M, Timmerman R, Shan J, Heitjan DF, Liu W, Nguyen D, Hannan R, Garant A, Desai N, Jiang S Artificial Intelligence in Medicine 2021 Nov 121
- Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma
  Schoenhals JE, Mohamad O, Christie A, Zhang Y, Li D, Singla N, Bowman I, Arafat W, Hammers H, Courtney K, Cole S, Bagrodia A, Margulis V, Desai N, Garant A, Choy H, Timmerman R, Brugarolas J, Hannan R Advances in Radiation Oncology 2021 Sep 6
- A deep learning-based framework for segmenting invisible clinical target volumes with estimated uncertainties for post-operative prostate cancer radiotherapy
  Balagopal A, Nguyen D, Morgan H, Weng Y, Dohopolski M, Lin MH, Barkousaraie AS, Gonzalez Y, Garant A, Desai N, Hannan R, Jiang S Medical Image Analysis 2021 Aug 72
- Stereotactic Ablative Radiation (SAbR) for Oligometastatic RCC
  All S, Garant A, Hannan R Seminars in Radiation Oncology 2021 Jul 31 227-234
- Hydrogel Spacer Rectal Wall Infiltration Associated With Severe Rectal Injury and Related Complications After Dose Intensified Prostate Cancer Stereotactic Ablative Radiation Therapy
  McLaughlin MF, Folkert MR, Timmerman RD, Hannan R, Garant A, Hudak SJ, Costa DN, Desai NB Advances in Radiation Oncology 2021 Jul 6
- A Multi-Institutional Analysis of Radiation Dosimetric Predictors of Toxicity After Trimodality Therapy for Esophageal Cancer
  Garant A, Spears G, Routman D, Whitaker T, Liao Z, Harmsen W, Liu A, Haddock M, Hallemeier C, Lin S, Merrell K Practical Radiation Oncology 2021 Jul 11 e415-e425
- Optimizing treatment sequencing of chemotherapy for patients with rectal cancer: The KIR randomized phase II trial
  Garant A, Kavan P, Martin AG, Azoulay L, Vendrely V, Lavoie C, Vasilevsky CA, Boutros M, Faria J, Nguyen TN, Ferland E, Des Groseilliers S, Cloutier AS, Diec H, Drolet S, Richard C, Batist G, Vuong T Radiotherapy and Oncology 2021 Feb 155 237-245
- Evolving Brachytherapy Boost in Prostate Cancer in the Era of Hypofractionation
  Desai NB, Garant A, Hannan R, Folkert MR International Journal of Radiation Oncology Biology Physics 2020 Nov 108 914-916
- The reintroduction of radiotherapy into the integrated management of kidney cancer
  Dohopolski M, Hannan R, Wardak Z, Hammers H, Garant A Cancer Journal 2020 Sep 26 448-459
- Image Guided Adaptive Endorectal Brachytherapy in the Nonoperative Management of Patients With Rectal Cancer
  Garant A, Magnan S, Devic S, Martin AG, Boutros M, Vasilevsky CA, Ferland S, Bujold A, DesGroseilliers S, Sebajang H, Richard C, Vuong T International Journal of Radiation Oncology Biology Physics 2019 Dec 105 1005-1011
- A Comparison of Patient-Reported Health-Related Quality of Life During Proton Versus Photon Chemoradiation Therapy for Esophageal Cancer
  Garant A, Whitaker TJ, Spears GM, Routman DM, Harmsen WS, Wilhite TJ, Ashman JB, Sio TT, Rule WG, Neben Wittich MA, Martenson JA, Tryggestad EJ, Yoon HH, Blackmon S, Merrell KW, Haddock MG, Hallemeier CL Practical Radiation Oncology 2019 Nov 9 410-417
- Addition of Iodinated Contrast to Rectal Hydrogel Spacer to Facilitate MRI-Independent Target Delineation and Treatment Planning for Prostate Cancer
  Atluri PS, Gannavarapu BS, Timmerman RD, Garant A, Hannan R, Folkert MR, Desai NB Practical Radiation Oncology 2019 Nov 9 e528-e533
- Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer
  Zhang Y, Schoenhals J, Christie A, Mohamad O, Wang C, Bowman I, Singla N, Hammers H, Courtney K, Bagrodia A, Margulis V, Desai N, Garant A, Choy H, Timmerman R, Brugarolas J, Hannan R International Journal of Radiation Oncology Biology Physics 2019 Oct 105 367-375
- Optimization of HDRBT boost dose delivery for patients with rectal cancer
  Devic S, Bekerat H, Garant A, Vuong T Brachytherapy 2019 Jul 18 559-563
- A Comparison of Grade 4 Lymphopenia With Proton Versus Photon Radiation Therapy for Esophageal Cancer
  Routman DM, Garant A, Lester SC, Day CN, Harmsen WS, Sanheuza CT, Yoon HH, Neben-Wittich MA, Martenson JA, Haddock MG, Hallemeier CL, Merrell KW Advances in Radiation Oncology 2019 Jan 4 63-69
- Do clinical criteria reflect pathologic complete response in rectal cancer following neoadjuvant therapy?
  Garant A, Florianova L, Gologan A, Spatz A, Faria J, Morin N, Vasilevsky CA, Vuong T International Journal of Colorectal Disease 2018 Jun 33 727-733
- Neoadjuvant radiotherapy
  Vuong T, Garant A 2018 Jan 65-76
- Concomitant use of corticosteroids and immune checkpoint inhibitors in patients with hematologic or solid neoplasms: A systematic review
  Garant A, Guilbault C, Ekmekjian T, Greenwald Z, Murgoi P, Vuong T Critical Reviews in Oncology/Hematology 2017 Dec 120 86-92
- Long-term Outcomes of Induction Carboplatin and Gemcitabine Followed by Concurrent Radiotherapy With Low-dose Paclitaxel and Gemcitabine for Stage III Non–small-cell Lung Cancer
  Guilbault C, Garant A, Faria S, Owen S, Ofiara L, Duclos M, Hirsh V, Kopek N Clinical lung cancer 2017 Sep 18 565-571
- A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases
  Siddiqui MR, Simillis C, Hunter C, Chand M, Bhoday J, Garant A, Vuong T, Artho G, Rasheed S, Tekkis P, Abulafi AM, Brown G British journal of cancer 2017 Jun 116 1513-1519
- EGFR and K-ras gene mutation status in squamous cell anal carcinoma: A role for concurrent radiation and EGFR inhibitors
  Paliga A, Onerheim R, Gologan A, Chong G, Spatz A, Niazi T, Garant A, MacHeto D, Alcindor T, Vuong T British journal of cancer 2012 Nov 107 1864-1868
- Adverse features on rectal MRI identify a high-risk group that may benefit from more intensive preoperative staging and treatment
  Hunter CJ, Garant A, Vuong T, Artho G, Lisbona R, Tekkis P, Abulafi M, Brown G Annals of Surgical Oncology 2012 Apr 19 1199-1205
- Late Anastomotic Dehiscence during Bevacizumab Therapy for Patients with Colorectal Cancer
  Garant A, Des Groseilliers S, Martin L, Ferland É, Vuong T Clinical Oncology 2011 Sep 23 497-498
- Risk of Hypogonadism From Scatter Radiation During Pelvic Radiation in Male Patients With Rectal Cancer
  Yau I, Vuong T, Garant A, Ducruet T, Doran P, Faria S, Liberman S, Richard C, Letellier F, Charlebois P, Loungnarath R, Stein B, Devic S International Journal of Radiation Oncology Biology Physics 2009 Aug 74 1481-1486

Research

RCC spine metastases
Bladder cancer in women
Prostate cancer protocols
Rectal cancer in elderly patients

Clinical Focus

Brachytherapy
Genitourinary Cancer
Prostate Cancer
Penile Cancer
Skin Cancer
Kidney Cancer